Wednesday, June 10, 2026

Intelligence Β· INN directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed 4,797
Companies 1,769
Pipeline programs 20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

Showing page 123 of 200 Β· By data quality, then INN

  1. eladocagene exuparvovec

    UPSTAZA

    EMA: approved

    A16AB26
  2. eliglustat

    CERDELGA

    EMA: approved

    A16AX10
  3. elivaldogene autotemcel

    SKYSONA

    EMA: withdrawn

    N07
  4. emapalumab

    GAMIFANT

    EMA: refused

    L04AA39
  5. emedastine

    EMADINE

    EMA: approved

    S01GX06
  6. enclomifene

    ENCYZIX

    EMA: refused

    G03X
  7. enfortumab vedotin

    PADCEV Astellas Pharma Inc

    EMA: approved Β· TGA: approved

    L01FX13
  8. entolimod

    ENTOLIMOD TMC

    EMA: application withdrawn

    L03A
  9. epcoritamab

    EPKINLY AbbVie

    EMA: approved Β· TGA: approved

    L01FX27
  10. eplontersen

    WAINZUA

    EMA: approved

    N07XX21
  11. epoetin beta

    NEORECORMON Hoffmann-La Roche

    EMA: approved Β· TGA: approved

    B03XA01
  12. epoetin delta

    DYNEPO

    EMA: withdrawn

    B03XA
  13. epoetin zeta

    RETACRIT

    EMA: approved

    B03XA01
  14. eprodisate disodium

    KIACTA

    EMA: application withdrawn

  15. eptacog alfa (activated)

    HEMARYO

    EMA: approved Β· PMDA: approved

    B02BD08
  16. eptacog beta (activated)

    CEVENFACTA

    EMA: approved

    B02BD08
  17. eptinezumab

    VYEPTI

    EMA: approved Β· TGA: approved

    N02CD
  18. eptotermin alfa

    OSIGRAFT

    EMA: withdrawn

    M05BC02
  19. eravacycline

    XERAVA

    EMA: approved

    J01AA13
  20. erenumab

    AIMOVIG

    EMA: approved

    N02CD01
  21. eribulin

    ERIBULIN DR.REDDY''S Eisai Co.,

    EMA: approved Β· TGA: approved

    L01XX41
  22. erlotinib

    ERLOTINIB ARX Lacuna Pharma Pty Ltd

    EMA: approved Β· TGA: approved Β· NMPA: clinical trials

    L01EB02
  23. ertapenem

    INVANZ

    EMA: approved

    J01DH03
  24. esketamine

    SPRAVATO Janssen-Cilag Pty Ltd

    EMA: approved Β· TGA: approved Β· NMPA: clinical trials

    N06AX27

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles β€” INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page β€” it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.